Background A practical biomarker is required to facilitate the preclinical diagnosis of Alzheimer's
disease (AD). Methods Plasma amyloid beta (Aβ) 1–40 , Aβ 1–42 , Aβ n–40 , and Aβ n–…

Lower hemoglobin is associated with cognitive impairment and Alzheimer's disease (AD).
Since brain iron homeostasis is perturbed in AD, we investigated whether this is peripherally …

There is some debate regarding the differing levels of plasma homocysteine, vitamin B12
and serum folate between healthy controls (HC), mild cognitive impairment (MCI), and …

Previously, we reported the isolation of 10 vancomycin-resistant gram-positive anaerobic
bacilli carrying the vanB ligase gene from nine hemodialysis patients (SA Ballard et al., …

Objective: The current study aimed to determine CSF biomarker cut-points using positron
emission tomography (PET) Aß imaging screened subjects from the Australian Imaging, …

OBJECTIVE: Refractive errors such as myopia and hypermetropia are among the leading
causes of visual impairment worldwide. Several genetic loci have been associated with …

Background: Several studies have reported that peripheral levels of copper and ceruloplasmin
(CP) can differentiate patients with Alzheimer’s disease (AD) from non-AD cases. The aim …

Increasing evidence suggests that kynurenine pathway (KP) dyshomeostasis may promote
disease progression in dementia. Studies in Alzheimer's disease (AD) patients confirm KP …

Background The Australian Imaging and Biomarker Lifestyle (AIBL) study of aging is
designed to aid the discovery of biomarkers. The current study aimed to discover differentially …

purpose. Transforming growth β-induced factor (TGIF) has been identified as a candidate
gene for high myopia through genetic linkage studies and through its role in ocular growth in …